![Margaret Alexander](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 153 758 $ al 30/09/2026
Margaret Alexander is President, Chief Executive Officer & Director at Ovid Therapeutics, Inc. since 2026.
Formerly, Ms. Alexander was Managing Director-Reputation & Risk Management at Syneos Health, Inc. from 2015 to 2020.
Ms. Alexander completed undergraduate studies at The College of William & Mary.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
OVID THERAPEUTICS INC. 0,03 % | 17/04/2026 | 61.750 ( 0,03 % ) | 153 758 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| OVID THERAPEUTICS INC. | Director Ejecutivo | 01/01/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| SYNEOS HEALTH, INC. | Corporate Officer/Principal | 01/06/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Ovid Therapeutics, Inc.
 Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
The College of William & Mary
 The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syneos Health, Inc.
 Syneos Health, Inc. BiotechnologyHealth Technology Provides outsourced clinical development and commercialization services to biopharmaceutical companies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
